These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
635 related items for PubMed ID: 30606674
1. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. Wang YT, Shi TQ, Zhu HL, Liu CH. Bioorg Med Chem; 2019 Feb 01; 27(3):502-515. PubMed ID: 30606674 [Abstract] [Full Text] [Related]
2. Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents. Zhang YL, Yang R, Xia LY, Man RJ, Chu YC, Jiang AQ, Wang ZC, Zhu HL. Bioorg Chem; 2019 Nov 01; 92():103219. PubMed ID: 31476616 [Abstract] [Full Text] [Related]
3. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors. Qin YJ, Li YJ, Jiang AQ, Yang MR, Zhu QZ, Dong H, Zhu HL. Eur J Med Chem; 2015 Apr 13; 94():447-57. PubMed ID: 25828827 [Abstract] [Full Text] [Related]
4. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents. Kamal A, Shaik AB, Rao BB, Khan I, Bharath Kumar G, Jain N. Org Biomol Chem; 2015 Oct 28; 13(40):10162-78. PubMed ID: 26303171 [Abstract] [Full Text] [Related]
5. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Wang YT, Qin YJ, Yang N, Zhang YL, Liu CH, Zhu HL. Eur J Med Chem; 2015 Jun 24; 99():125-37. PubMed ID: 26070164 [Abstract] [Full Text] [Related]
6. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors. Wang YT, Cai XC, Shi TQ, Zhang YL, Wang ZC, Liu CH, Zhu HL. Chem Biol Drug Des; 2017 Jul 24; 90(1):112-118. PubMed ID: 28032450 [Abstract] [Full Text] [Related]
7. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors. Behbahani FS, Tabeshpour J, Mirzaei S, Golmakaniyoon S, Tayarani-Najaran Z, Ghasemi A, Ghodsi R. Arch Pharm (Weinheim); 2019 Jun 24; 352(6):e1800307. PubMed ID: 31012156 [Abstract] [Full Text] [Related]
8. Synthesis and Biological Evaluation of 1-Methyl-1H-indole-Pyrazoline Hybrids as Potential Tubulin Polymerization Inhibitors. Zhang YL, Qin YJ, Tang DJ, Yang MR, Li BY, Wang YT, Cai HY, Wang BZ, Zhu HL. ChemMedChem; 2016 Jul 05; 11(13):1446-58. PubMed ID: 27159418 [Abstract] [Full Text] [Related]
9. Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents. Kamal A, Shaik AB, Jain N, Kishor C, Nagabhushana A, Supriya B, Bharath Kumar G, Chourasiya SS, Suresh Y, Mishra RK, Addlagatta A. Eur J Med Chem; 2015 Mar 06; 92():501-13. PubMed ID: 25599948 [Abstract] [Full Text] [Related]
10. New benzimidazole-2-urea derivates as tubulin inhibitors. Wang W, Kong D, Cheng H, Tan L, Zhang Z, Zhuang X, Long H, Zhou Y, Xu Y, Yang X, Ding K. Bioorg Med Chem Lett; 2014 Sep 01; 24(17):4250-3. PubMed ID: 25091926 [Abstract] [Full Text] [Related]
11. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S, An B, Li Y, Luo X, Li X, Jia X. Bioorg Med Chem Lett; 2018 Jun 01; 28(10):1769-1775. PubMed ID: 29673981 [Abstract] [Full Text] [Related]
12. Design, synthesis, and biological evaluation of 2,3-diphenyl-cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors. Xia LY, Yang R, Zhang YL, Chu YC, Qi YL, Man RJ, Wang ZC, Wang BZ, Zhu HL. Chem Biol Drug Des; 2019 Sep 01; 94(5):1894-1904. PubMed ID: 31106514 [Abstract] [Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition. Li SS, Chen JJ, Zhang MM, Wang WX, Zhang WY, Ma C. Eur J Med Chem; 2024 May 05; 271():116425. PubMed ID: 38636129 [Abstract] [Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site. Liu YN, Wang JJ, Ji YT, Zhao GD, Tang LQ, Zhang CM, Guo XL, Liu ZP. J Med Chem; 2016 Jun 09; 59(11):5341-55. PubMed ID: 27172319 [Abstract] [Full Text] [Related]
15. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Rahimzadeh Oskuei S, Mirzaei S, Reza Jafari-Nik M, Hadizadeh F, Eisvand F, Mosaffa F, Ghodsi R. Bioorg Chem; 2021 Jul 09; 112():104904. PubMed ID: 33933802 [Abstract] [Full Text] [Related]
16. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents. Yang J, Yang S, Zhou S, Lu D, Ji L, Li Z, Yu S, Meng X. Eur J Med Chem; 2016 Oct 21; 122():488-496. PubMed ID: 27423028 [Abstract] [Full Text] [Related]
17. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors. Wang G, Liu W, Gong Z, Huang Y, Li Y, Peng Z. Bioorg Chem; 2020 Jan 21; 95():103565. PubMed ID: 31927336 [Abstract] [Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo. Pang Y, Lin H, Ou C, Cao Y, An B, Yan J, Li X. Eur J Med Chem; 2019 Nov 15; 182():111670. PubMed ID: 31499359 [Abstract] [Full Text] [Related]
19. Design, synthesis and biological evaluation of 1, 4-dihydro indeno[1,2-c] pyrazole linked oxindole analogues as potential anticancer agents targeting tubulin and inducing p53 dependent apoptosis. Khan I, Garikapati KR, Shaik AB, Makani VKK, Rahim A, Shareef MA, Reddy VG, Pal-Bhadra M, Kamal A, Kumar CG. Eur J Med Chem; 2018 Jan 20; 144():104-115. PubMed ID: 29268127 [Abstract] [Full Text] [Related]
20. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. Akhtar MJ, Khan AA, Ali Z, Dewangan RP, Rafi M, Hassan MQ, Akhtar MS, Siddiqui AA, Partap S, Pasha S, Yar MS. Bioorg Chem; 2018 Aug 20; 78():158-169. PubMed ID: 29571113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]